Feb 13, 2024 ˇ ... Vistagen Corporate Presentation 1.8 MB. NASDAQ CM VTGN $4.35 +0.07 (0.00%). Data as of Mar 26, 2024 | 4:00 PM EDT. Annual Reports. Stock Chart ...
People also ask
What is the target price for VTGN?
Why is Vistagen stock dropping?
What is the stock price forecast for VTGN in 2025?
Who owns VTGN stock?
... VTGN $4.15 0 (0.00%). Data as of Mar 19, 2024 | 4 ... Vistagen Therapeutics, Inc. 343 Allerton Avenue South San Francisco, CA 94080. Investor Relations ...
... VTGN $5.05 +0.48 (+10.50%). Data as of Mar 28, 2024 | 12:16 PM EDT. Be the ... Investors ˇ Investors Overview ˇ Stock Information ˇ Press Releases ˇ Events ˇ SEC ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Find the latest Vistagen Therapeutics, Inc. (VTGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Feb 13, 2024 ˇ It is now my pleasure to introduce Mark McPartland, Senior Vice President, Investor Relations at Vistagen. Thank you. you may begin. Mark ...
Find annual and quearterly earnings data for VistaGen Therapeutics, Inc. Common Stock (VTGN) including earnings per share, earnings forecasts at Nasdaq.com.
(US:VTGN) has 63 institutional owners and shareholders ... Investor Shares, Sphera Funds Management Ltd ... Corporate Presentation, dated January 2024. 01-09 ...
Vistagen Therapeutics, Inc. (VTGN) Company Profile & Facts
finance.yahoo.com › quote › VTGN › profile
Senior Vice President of Investor Relations, 300k, N/A, 1966. Ms. Trisha Fitzmaurice, Senior Vice President of Human Resources, N/A, N/A, N/A. Dr. Allen Easley ...
VistaGen Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View VTGN financial statements in full.